Trump touts a major TrumpRx expansion, adding more than 600 generic drugs

President Donald Trump expanded the TrumpRx website on Monday, adding more than 600 generic drugs to the government’s platform, which now offers nearly seven times the initial 40 medications launched in February. The site, designed to help Americans reduce prescription costs, partners with online pharmacies like Amazon Pharmacy, GoodRx, and Mark Cuban’s Cost Plus Drugs to facilitate purchases through drugmakers’ direct websites and provide pharmacy coupons. Since its launch, TrumpRx has been visited over 10 million times, though its utility varies by patient—insured individuals typically save more through insurance, while uninsured or high-deductible patients may benefit from discounts. Trump framed the expansion as a response to Democratic criticism that TrumpRx was ineffective, highlighting affordability as a key voter concern amid rising health costs and recent Medicaid cuts. The administration has also pursued other drug pricing measures, including deals with 17 major pharmaceutical companies to align U.S. drug prices with those in other developed nations, though details remain undisclosed. Experts, including Boston University professor Rena Conti, emphasized that the addition of generics broadens options for those without insurance or facing high out-of-pocket costs. Mark Cuban, a political independent who endorsed Democrat Kamala Harris in 2024, praised TrumpRx’s cost-saving potential, particularly for drugs like IVF treatments. Despite past political differences, Trump and Cuban shared a stage, both advocating for lower drug prices. The administration’s broader efforts to curb prescription costs have drawn scrutiny from lawmakers seeking transparency on the private pricing agreements. TrumpRx does not sell medications directly but directs users to drugmakers’ websites and offers coupons for in-person pharmacies. The platform’s growth reflects ongoing efforts to address prescription affordability, though its impact remains limited for those with insurance coverage. With midterm elections approaching, the expansion positions TrumpRx as a tangible policy achievement amid broader debates over healthcare costs.